HUMILAC

Main information

  • Trade name:
  • HUMILAC DRY SKIN SPRAY AND RINSE OIL FREE HUMECTANT
  • Pharmaceutical form:
  • TOPICAL AEROSOL SPRAY
  • Units in package:
  • 237mL
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • VIRBAC

Documents

Localization

  • Available in:
  • HUMILAC DRY SKIN SPRAY AND RINSE OIL FREE HUMECTANT
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • CAT | DOG | HORSE | LABORATORY ANIMAL | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | COLT | DONKEY | ENDURANCE HORSE | FILLY | F
  • Therapeutic area:
  • humectant
  • Therapeutic indications:
  • KERATOLYTIC OR CLEANING AGENT | BIOTIN DEFICIENCY | BRITTLE HOOF | CLEANSING AGENTS | COAT APPEARANCE | CONDITIONING | CONJUNCTIVITIS | CRACKED HOOF | DRY SKIN | FLAKING | GALLS | GROOMING AIDS | HOOF CONDITIONING | HOOF MOISTURISING | HOPPLE CHAFES | ITCHING | LAMINITIS | MOISTURISING | PLIABILITY | PSORIASIS | SCRATCHES | SKIN CLEANSER | WART REMOVAL
  • Product summary:
  • Oil free humectant for use on dogs, cats, horses and laboratory animals.

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Registered but not available
  • Authorization number:
  • 35569/1299
  • Authorization date:
  • 09-12-1999
  • Last update:
  • 15-06-2017

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation

4 February, 2000

Page 1 of 1 Intermediate Label - Humilac

_______________________________________________________________________________________________

Infopest verifies that this label is consistent with the NRA

Approved Text Label of 9/12/99

FOR ANIMAL TREATMENT ONLY

H

UMILAC

DRY SKIN SPRAY AND RINSE OIL-FREE HUMECTANT

ACTIVE CONSTITUENTS:

106.0 mg/mL PROPYLENE GLYCOL

106.0 mg/mL UREA

53.0 mg/mL LACTIC ACID

79.5 mg/mL GLYCERINE

1.06 mg/mL BENZALKONIUM CHLORIDE

Oil-free Humectant for use on dogs, cats, horses and

laboratory animals.

ALLERDERM

A division of VIRBAC

237 mL

Indications:

HUMILAC

is a unique, soothing dry skin treatment incorporating an oil-free humectant. Specially formulated

to aid in moisturising dry skin and in restoring lustre to the hair coat without leaving a greasy or oily film.

DIRECTIONS FOR USE:

While parting the hair, thoroughly spray the entire coat. Groom as usual. Use daily or as recommended by

your veterinarian. May be used as an after shampoo rinse. Add 5 capfuls (25 mL) of

HUMILAC

to 1 litre of

warm water. Pour the solution over the animal, avoiding eyes and ears.

WITHHOLDING PERIODS NIL

VIRBAC (AUSTRALIA) PTY. LIMITED

Distributed in New Zealand by:

15 Pritchard Place, Peakhurst NSW 2210

VIRBAC LABORATORIES (NZ) LTD

30 Stonedon Drive, East Tamaki, Auckland.

DISPOSAL:

Dispose of empty container by wrapping with paper and putting in garbage.

STORAGE:

Store below 30°C (Room Temperature).

Registered Trade Mark of Virbac.

[B]:

CODE:

EXP:

NRA: 35569 /1299

12-1-2019

Scientific Opinion on Flavouring Group Evaluation 208 Revision 3 (FGE.208Rev3): consideration of genotoxicity data on alicyclic aldehydes with α,β‐unsaturation in ring/side‐chain and precursors from chemical subgroup 2.2 of FGE.19

Scientific Opinion on Flavouring Group Evaluation 208 Revision 3 (FGE.208Rev3): consideration of genotoxicity data on alicyclic aldehydes with α,β‐unsaturation in ring/side‐chain and precursors from chemical subgroup 2.2 of FGE.19

Published on: Fri, 11 Jan 2019 The EFSA Panel on Food Additives and Flavourings was requested to evaluate the genotoxic potential of flavouring substances from subgroup 2.2 of FGE.19 in the Flavouring Group Evaluation 208 Revision 3 (FGE.208Rev3). In FGE.208Rev1, the Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) evaluated genotoxicity studies on the representative substance p‐mentha‐1,8‐dien‐7‐al [FL‐no: 05.117], which was found to be genotoxic in vivo. The Panel conclu...

Europe - EFSA - European Food Safety Authority EFSA Journal

12-1-2019

Safety evaluation of the food enzyme endo‐1,4‐β‐xylanase from Bacillus subtilis (strain XAS)

Safety evaluation of the food enzyme endo‐1,4‐β‐xylanase from Bacillus subtilis (strain XAS)

Published on: Fri, 11 Jan 2019 The EFSA Panel on Food Additives and Flavourings was requested to evaluate the genotoxic potential of flavouring substances from subgroup 2.2 of FGE.19 in the Flavouring Group Evaluation 208 Revision 3 (FGE.208Rev3). In FGE.208Rev1, the Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) evaluated genotoxicity studies on the representative substance p‐mentha‐1,8‐dien‐7‐al [FL‐no: 05.117], which was found to be genotoxic in vivo. The Panel conclu...

Europe - EFSA - European Food Safety Authority EFSA Journal

13-7-2018

Hospira Issues Voluntary Nationwide Recall of Daptomycin for Injection Lyophilized Powder for Solution, Due to Infusion Reactions

Hospira Issues Voluntary Nationwide Recall of Daptomycin for Injection Lyophilized Powder for Solution, Due to Infusion Reactions

Hospira, Inc., a Pfizer company, is voluntarily recalling 8 lots of Hospira’s Daptomycin for Injection 500 mg, Lyophilized Powder For Solution, Single Dose Vial (NDC 0409-0106-01) to the Hospital/Retail level. The product is being recalled due to adverse event reports indicative of infusion reactions.

FDA - U.S. Food and Drug Administration

21-11-2018

EU/3/18/2086 (Santhera Pharmaceuticals (Deutschland) GmbH)

EU/3/18/2086 (Santhera Pharmaceuticals (Deutschland) GmbH)

EU/3/18/2086 (Active substance: Cyclo[L-alanyl-L-seryl-L-isoleucyl-L-prolyl-L-prolyl-L-glutaminyl-L-lysyl-L-tyrosyl-D-prolyl-L-prolyl-(2S)-2-aminodecanoyl-L-alpha-glutamyl-L-threonyl]acetate) - Orphan designation - Commission Decision (2018)7795 of Wed, 21 Nov 2018 European Medicines Agency (EMA) procedure number: EMA/OD/106/18

Europe -DG Health and Food Safety

27-7-2018

EU/3/12/1066 (Pfizer Europe MA EEIG)

EU/3/12/1066 (Pfizer Europe MA EEIG)

EU/3/12/1066 (Active substance: tafamidis) - Transfer of orphan designation - Commission Decision (2018)5066 of Fri, 27 Jul 2018 European Medicines Agency (EMA) procedure number: EMA/OD/115/12/T/01

Europe -DG Health and Food Safety

16-5-2018

EU/3/12/1063 (Novartis Europharm Limited)

EU/3/12/1063 (Novartis Europharm Limited)

EU/3/12/1063 (Active substance: Panobinostat) - Transfer of orphan designation - Commission Decision (2018)3041 of Wed, 16 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/113/12/T/01

Europe -DG Health and Food Safety